NCT03278886View on ClinicalTrials.gov

St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Nalmefene

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

July 3, 2018

Primary Completion Date

December 19, 2018

Study Completion Date

December 19, 2018

Conditions
HIV InfectionAlcohol UsePain
Interventions
DRUG

Low dose naltrexone

4.5 mg of low dose naltrexone taken once daily for 8 weeks

DRUG

Nalmefene

18 mg of nalmefene taken once daily for 8 weeks

Trial Locations (1)

197022

First St. Petersburg Pavlov State Medical University, Saint Petersburg

Sponsors
All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Boston Medical Center

OTHER

NCT03278886 - St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Nalmefene | Biotech Hunter | Biotech Hunter